Peptides targeting angiogenesis related growth factor receptors
- PMID: 19601840
- DOI: 10.2174/138161209788682235
Peptides targeting angiogenesis related growth factor receptors
Abstract
Growth factors (GFs) are extracellular signaling polypeptides regulating cell proliferation, differentiation and survival. They exert a wide spectrum of biological activities selectively binding to and activating specific membrane receptors which then transfer the message to cell interior inducing specific biochemical pathways. GFs are especially involved in the regulation of angiogenesis, a physiological process underlining several pathologies. Molecules able to modulate angiogenesis, interfering with the molecular recognition between a GF and its receptor, have a big pharmacologic interest. Either GF and the receptor are potential drug target. Peptides are useful molecules to develop new lead compounds disrupting protein-protein interface for pharmacological applications. In this review we describe peptides targeting the receptors of the pro-angiogenic growth factors FGF, PDGF and VEGF. The biological function and the structure of each growth factor/receptor system are discussed, as well as the molecular interaction between peptides and the receptors. Finally, we highlight the pharmacological and diagnostic applications of these peptides in angiogenesis related diseases.
Similar articles
-
Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.Oncologist. 2015 Jun;20(6):660-73. doi: 10.1634/theoncologist.2014-0465. Epub 2015 May 22. Oncologist. 2015. PMID: 26001391 Free PMC article. Review.
-
Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.Prog Biophys Mol Biol. 2013 Nov;113(2):333-54. doi: 10.1016/j.pbiomolbio.2013.10.001. Epub 2013 Oct 15. Prog Biophys Mol Biol. 2013. PMID: 24139944 Review.
-
Growth factors as active participants in carcinogenesis: a perspective.Vet Pathol. 2010 Jan;47(1):77-97. doi: 10.1177/0300985809352981. Vet Pathol. 2010. PMID: 20080487 Review.
-
Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions.Hum Reprod. 2006 Jan;21(1):262-8. doi: 10.1093/humrep/dei308. Epub 2005 Sep 19. Hum Reprod. 2006. PMID: 16172144
-
Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.IDrugs. 2003 Mar;6(3):224-31. IDrugs. 2003. PMID: 12789611 Review.
Cited by
-
Fibroblast growth factor-4 enhances proliferation of mouse embryonic stem cells via activation of c-Jun signaling.PLoS One. 2013 Aug 13;8(8):e71641. doi: 10.1371/journal.pone.0071641. eCollection 2013. PLoS One. 2013. PMID: 23967228 Free PMC article.
-
The powerful functions of peptide-based bioactive matrices for regenerative medicine.Ann Biomed Eng. 2015 Mar;43(3):501-14. doi: 10.1007/s10439-014-1166-6. Epub 2014 Nov 4. Ann Biomed Eng. 2015. PMID: 25366903 Free PMC article. Review.
-
Effect of attenuation of fibroblast growth factor receptor 2b signaling on odontoblast differentiation and dentin formation.In Vitro Cell Dev Biol Anim. 2019 Mar;55(3):211-219. doi: 10.1007/s11626-019-00323-w. Epub 2019 Feb 12. In Vitro Cell Dev Biol Anim. 2019. PMID: 30756235
-
Biochemical and Conformational Characterization of Recombinant VEGFR2 Domain 7.Mol Biotechnol. 2019 Nov;61(11):860-872. doi: 10.1007/s12033-019-00211-4. Mol Biotechnol. 2019. PMID: 31531759
-
Fibroblast growth factor-7 facilitates osteogenic differentiation of embryonic stem cells through the activation of ERK/Runx2 signaling.Mol Cell Biochem. 2013 Oct;382(1-2):37-45. doi: 10.1007/s11010-013-1716-5. Epub 2013 Jun 4. Mol Cell Biochem. 2013. PMID: 24026476
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources